Latest Payments News

Block, Inc. delivered a robust Q2 2026 with 25% gross profit growth, driven by strong Cash App and Square performances, and raised its full-year guidance reflecting accelerating AI integration and hardware innovation.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

GoldArc Resources (ASX:GA8) has struck a binding deal to acquire seven tenements from Regener8 Resources, extending its Leonora South gold corridor in Western Australia. The move consolidates contiguous ground adjacent to existing high-grade deposits, positioning GoldArc for accelerated exploration.

Infinity Metals has locked in an exclusive option to acquire 100% of the Tule Canyon molybdenum-copper project in Nevada, a historically explored porphyry deposit with promising drill results and strategic positioning amid soaring molybdenum prices.

Argo Investments reported a stable $260.2 million profit for FY2026, declared a record fully franked 38.5c dividend, and announced a shift to quarterly dividends from January 2027 with a forecast 40c annual payout.

GWR Group plans a $19.85 million capital return equating to 6.1 cents per share, pending shareholder approval. The ASX has granted a waiver allowing the share price to fall below 20 cents post-distribution, enabling the return to proceed.

JPMorgan Asset Management has revised the estimated cash distributions for its four Equity Premium Income Complex ETFs for August 2026, with payments scheduled mid-month.

Whitefield Industrials Limited (ASX:WHF) has announced an on-market buy-back program targeting up to 12 million ordinary shares, aiming to adjust its capital structure without requiring shareholder approval.

Fitzroy River Corporation has appointed Argonaut Corporate Finance as exclusive adviser to test market interest in selling its Bowdens Silver Project royalty, with no sale decision yet made.

CurveBeam AI has launched a Share Purchase Plan offering eligible shareholders a 10% discount on new shares, aiming to raise up to $2 million alongside a pending $5 million placement.

Lumos Diagnostics has landed a US$767,800 purchase order for its FebriDx rapid test from PHASE Scientific, marking a key step in commercialising its FDA-approved product ahead of the US flu season.

Tusker Minerals has inked a binding deal to sell its Machinga Rare Earth Elements project in Malawi to AuKing Mining for up to A$4 million, freeing capital to concentrate on its high-grade rutile and heavy mineral sands assets.